KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,390,233 | -37.9% | 113,674 | -37.0% | 0.12% | -32.4% |
| Q4 2022 | $2,240,005 | -24.9% | 180,500 | -17.3% | 0.18% | -29.2% |
| Q3 2022 | $2,983,000 | -30.5% | 218,366 | -6.8% | 0.25% | -30.3% |
| Q2 2022 | $4,294,000 | +13.9% | 234,273 | -0.0% | 0.36% | +22.6% |
| Q1 2022 | $3,769,000 | +23.2% | 234,372 | +7.3% | 0.30% | +51.8% |
| Q4 2021 | $3,059,000 | -18.3% | 218,497 | +9.2% | 0.20% | -16.3% |
| Q3 2021 | $3,746,000 | +27.1% | 200,015 | +41.5% | 0.23% | +56.4% |
| Q2 2021 | $2,947,000 | -0.0% | 141,346 | +35.5% | 0.15% | -24.0% |
| Q1 2021 | $2,948,000 | – | 104,293 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |